http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0890571-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e83d93ed02bbd6159e99b5a7796e3686
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C213-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C219-24
filingDate 1998-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30148f694468e5ee63b3be1f7ad5a027
publicationDate 1999-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0890571-A1
titleOfInvention Process for the preparation of(1S,2R)-1-amino-2-indanol-(R,R)-tartrate methanol solvate
abstract Process for the preparation of (1S,2R)-1-amino-2-indanol-(R,R)-tartratenmethanol solvate, in which in ansolvent a mixture of enantiomers of cis-1-amino-2-indanolnreacts at an elevated temperature with (R,R)-tartaric acidnand methanol and in which optically enriched (1S,2R)-1-amino-2-indanol-(R,R)-tartratenmethanol solvatencrystallizes out, after which the crystals are recovered,nthe recovery taking place at a temperature between 10 andn50°C in the presence of 0-20 wt.% water relative to thenamount of methanol plus solvent, on the understanding thatnif the reaction mixture is essentially free from water thenrecovery substantially takes place at a temperaturenbetween 30 and 50°C. Preferably the reactants are at leastnin part contacted with each other at an elevatedntemperature and only methanol is used as solvent.nPreferably the amount of (1S,2R)-1-amino-2-indanol appliednis between 0.02 and 0.1 g per ml of solvent. n The invention also relates to (1S,2R)-1-amino-2-indanol-(R,R)-tartratenmethanol solvate crystals having anparticle size larger than 95 µm, expressed as D[v, 0.9],nin particular those in which the enantiomeric excess ofn(1S,2R)-1-amino-2-indanol-(R,R)-tartrate relative ton(1R,2S)-1-amino-2-indanol-(R,R)-tartrate is higher thann96%, as well as to application of (1S,2R)-1-amino-2-indanol-(R,R)-tartratenmethanol solvate in the preparationnof AIDS inhibitors, in particular indinavir sulphate.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7544841-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2891647-A4
priorityDate 1997-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5420353-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9866743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232628729
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454374137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53841338
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454374135
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232623471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502998
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450268500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232617930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226526300
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420352779
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232617925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136083124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426153
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420332851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408499458
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232623470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135998608
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462355
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128519272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226526299
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362440
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127962043
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID139034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128519268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135934852
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15870238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69944163
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2725045
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57134941
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127836867
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21133356
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69945409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232628734
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21133357
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226462076
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69946670

Total number of triples: 64.